Skip to main content
OpenTrials
Completed

NCT Number: NCT05293262

Endourological Management of Stones During COVID19

Guidelines for endourological procedures during COVID-19 have suggested deferring all elective procedures, while obstructed/ infected stones should undergo urgent decompression.

At our centre, screening protocols were implemented with prioritization strategies so that elective care could safely continue at deescalated rates. COVID or septic patients underwent emergency decompression, while non-COVID and non-septic patients underwent primary ureteroscopy (URS) or retrograde intrarenal surgery (RIRS).

We aim to report our experience with endourological surgery for stone disease during COVID-19.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Urolithiasis COVID-19 Coronaviridae Infections Coronavirus Infections Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Infections Lung Diseases Male Urogenital Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Urogenital Diseases Urologic Diseases Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Ng Teng Fong General Hospital, Singapore

Singapore, 609606

About this study

We conducted a retrospective review of a prospectively maintained database of all endourological surgeries for stones in our centre during the first wave of COVID19.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patient with urolithiasis who underwent endourological interventions during COVID19 pandemic

Treatment and study plan

Endourological surgery

Procedure

Includes ureteral stent insertion, ureteroscopies and retrograde intrarenal surgeies

Primary outcomes

  1. Length of hospital stay

    Time frame: From admission to discharge from hospital, up to 3 months

    Length of hospital stay

  2. Complication rate

    Time frame: From admission up to 3 months post operatively

    Complications as defined by Clavien Dindo classification system

  3. Stone free rate

    Time frame: At follow up visit in clinic 3 months post procedure

Secondary outcomes

  1. Readmission rate

    Time frame: From discharge up to three months post operatively

Sponsors and collaborators

Lead sponsor

Roxanne Teo

Other

Registry information

Official study title

Definitive Endourological Interventions for Urolithiasis Management During COVID19- Outcomes From a Cohort Study

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Mar 24, 2022
Registry last updated
Mar 24, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.